VR Logo

Theseus Pharmaceuticals Inc. (THRX) download report


Healthcare | Biotechnology & Pharma Research

Theseus Pharmaceuticals Inc. (THRX) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients.

IPO Date: 07-Oct-2021

Co-Founder & Chairman: Dr. Iain D. Dukes D.Phil., DPHIL, M.A.

CEO, Pres & Director: Dr. Timothy P. Clackson Ph.D.

Listing: NASDAQ: THRX

Country: United States

Headquarters: Cambridge, MA

Website: https://theseusrx.com

Key Facts

Market cap: $205.90 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-32.17 Mln

Cash: $232.04 Mln

Total Debt: $4.72 Mln

Insider's Holding: 3.57%

Liquidity: Low

52 Week range: $4.86 - 24.54

Shares outstanding: 38,702,600

Stock Performance

Time Period Theseus Pharmaceuticals (THRX) S&P BSE Sensex S&P Small-Cap 600
YTD-55.84-8.99-19.23
1 month-19.89-3.40-9.35
3 months-54.73-8.50-16.59
1 Year--0.89-17.36
3 Years--10.415.90
5 Years--11.435.77
10 Years--11.779.78
As on 30-Jun-2022